,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,481659,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,150084,IGSF5,https://ctdbase.org/detail.go?type=gene&acc=150084,,,150084,IGSF5,10116,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of IGSF5 mRNA,,,PMID:24793618,https://www.ncbi.nlm.nih.gov/pubmed/24793618,24793618,,
1,481660,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,10261,IGSF6,https://ctdbase.org/detail.go?type=gene&acc=10261,,,10261,IGSF6,10116,Rattus norvegicus (Norway rat),Flutamide results in increased expression of IGSF6 mRNA,,,PMID:24793618,https://www.ncbi.nlm.nih.gov/pubmed/24793618,24793618,,
2,481661,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,3550,IK,https://ctdbase.org/detail.go?type=gene&acc=3550,,,3550,IK,10116,Rattus norvegicus (Norway rat),Flutamide results in increased expression of IK mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
3,481662,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,8517,IKBKG,https://ctdbase.org/detail.go?type=gene&acc=8517,,,8517,IKBKG,10116,Rattus norvegicus (Norway rat),Flutamide results in increased expression of IKBKG mRNA,,,PMID:24793618,https://www.ncbi.nlm.nih.gov/pubmed/24793618,24793618,,
4,481663,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586,IL10,10116,Rattus norvegicus (Norway rat),Flutamide affects the expression of IL10 protein,,,PMID:25051504,https://www.ncbi.nlm.nih.gov/pubmed/25051504,25051504,,
5,483167,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,3712,IVD,https://ctdbase.org/detail.go?type=gene&acc=3712,,,3712,IVD,10116,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of IVD mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
6,483168,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,10625,IVNS1ABP,https://ctdbase.org/detail.go?type=gene&acc=10625,,,10625,IVNS1ABP,10116,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of IVNS1ABP mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
7,483169,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,55677,IWS1,https://ctdbase.org/detail.go?type=gene&acc=55677,,,55677,IWS1,10116,Rattus norvegicus (Norway rat),Flutamide results in increased expression of IWS1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
8,483170,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,389434,IYD,https://ctdbase.org/detail.go?type=gene&acc=389434,,,389434,IYD,10116,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of IYD mRNA,,,PMID:24136188|PMID:24793618,https://www.ncbi.nlm.nih.gov/pubmed/24136188|https://www.ncbi.nlm.nih.gov/pubmed/24793618,24136188|24793618,,
9,483171,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,79960,JADE1,https://ctdbase.org/detail.go?type=gene&acc=79960,,,79960,JADE1,10116,Rattus norvegicus (Norway rat),Flutamide results in increased expression of JADE1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
10,483172,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,84522,JAGN1,https://ctdbase.org/detail.go?type=gene&acc=84522,,,84522,JAGN1,10116,Rattus norvegicus (Norway rat),Flutamide results in increased expression of JAGN1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
11,483173,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,3717,JAK2,https://ctdbase.org/detail.go?type=gene&acc=3717,,,3717,JAK2,10116,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of JAK2 mRNA,,,PMID:24793618,https://www.ncbi.nlm.nih.gov/pubmed/24793618,24793618,,
12,484224,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,687,KLF9,https://ctdbase.org/detail.go?type=gene&acc=687,,,687,KLF9,10116,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of KLF9 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
13,484225,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,23588,KLHDC2,https://ctdbase.org/detail.go?type=gene&acc=23588,,,23588,KLHDC2,10116,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of KLHDC2 mRNA,,,PMID:24793618,https://www.ncbi.nlm.nih.gov/pubmed/24793618,24793618,,
14,484226,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,23588,KLHDC2,https://ctdbase.org/detail.go?type=gene&acc=23588,,,23588,KLHDC2,10116,Rattus norvegicus (Norway rat),Flutamide results in increased expression of KLHDC2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
15,484218,3500,Drug Gene Interaction database (DGIdb),"3-[3-(Dimethylamino)-2-hydroxypropyl]-7-methoxy-23-methyl-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4(9),5,7,10,15,17,19,21-nonaene-12,14-dione",,YM-254890,https://www.dgidb.org/drugs/iuphar.ligand:9335,,BRAF,https://www.dgidb.org/genes/hgnc:1097,,,673,BRAF,9606,Homo sapiens (human),,,,,,,,
16,484219,3500,Drug Gene Interaction database (DGIdb),"3-[3-(Dimethylamino)-2-hydroxypropyl]-7-methoxy-23-methyl-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4(9),5,7,10,15,17,19,21-nonaene-12,14-dione",,YM-254890,https://www.dgidb.org/drugs/iuphar.ligand:9335,,NRAS,https://www.dgidb.org/genes/hgnc:7989,,,4893,NRAS,9606,Homo sapiens (human),,,,,,,,
17,484220,3536,Comparative Toxicogenomics Database (CTD),"4-[(7-oxo-6H-pyrrolo[2,3-g][1,3]benzothiazol-8-ylidene)methylamino]-N-(2-pyridinyl)benzenesulfonamide",C500810,GW8510,https://ctdbase.org/detail.go?type=chem&acc=C500810,317,APAF1,https://ctdbase.org/detail.go?type=gene&acc=317,,,317,APAF1,10090,Mus musculus (house mouse),GW8510 results in increased expression of APAF1 mRNA,,,PMID:22242153,https://www.ncbi.nlm.nih.gov/pubmed/22242153,22242153,,
18,484221,3536,Comparative Toxicogenomics Database (CTD),"4-[(7-oxo-6H-pyrrolo[2,3-g][1,3]benzothiazol-8-ylidene)methylamino]-N-(2-pyridinyl)benzenesulfonamide",C500810,GW8510,https://ctdbase.org/detail.go?type=chem&acc=C500810,637,BID,https://ctdbase.org/detail.go?type=gene&acc=637,,,637,BID,10090,Mus musculus (house mouse),GW8510 results in increased expression of BID mRNA,,,PMID:22242153,https://www.ncbi.nlm.nih.gov/pubmed/22242153,22242153,,
19,484222,3536,Comparative Toxicogenomics Database (CTD),"4-[(7-oxo-6H-pyrrolo[2,3-g][1,3]benzothiazol-8-ylidene)methylamino]-N-(2-pyridinyl)benzenesulfonamide",C500810,GW8510,https://ctdbase.org/detail.go?type=chem&acc=C500810,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9606,Homo sapiens (human),GW8510 inhibits the reaction [SNCA protein results in increased activity of CASP3 protein],,,PMID:24989254,https://www.ncbi.nlm.nih.gov/pubmed/24989254,24989254,,
20,484223,3536,Comparative Toxicogenomics Database (CTD),"4-[(7-oxo-6H-pyrrolo[2,3-g][1,3]benzothiazol-8-ylidene)methylamino]-N-(2-pyridinyl)benzenesulfonamide",C500810,GW8510,https://ctdbase.org/detail.go?type=chem&acc=C500810,840,CASP7,https://ctdbase.org/detail.go?type=gene&acc=840,,,840,CASP7,9606,Homo sapiens (human),GW8510 inhibits the reaction [SNCA protein results in increased activity of CASP7 protein],,,PMID:24989254,https://www.ncbi.nlm.nih.gov/pubmed/24989254,24989254,,
21,481501,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,6385,SDC4,https://ctdbase.org/detail.go?type=gene&acc=6385,,,6385,SDC4,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of SDC4 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
22,483697,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,6446,SGK1,https://ctdbase.org/detail.go?type=gene&acc=6446,,,6446,SGK1,90988,Pimephales promelas (fathead minnow),Indomethacin results in decreased expression of SGK1 mRNA,,,PMID:28201806,https://www.ncbi.nlm.nih.gov/pubmed/28201806,28201806,,
23,483698,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,259230,SGMS1,https://ctdbase.org/detail.go?type=gene&acc=259230,,,259230,SGMS1,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of SGMS1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
24,483699,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,166929,SGMS2,https://ctdbase.org/detail.go?type=gene&acc=166929,,,166929,SGMS2,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of SGMS2 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
25,483700,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,9905,SGSM2,https://ctdbase.org/detail.go?type=gene&acc=9905,,,9905,SGSM2,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of SGSM2 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
26,481840,3795,Comparative Toxicogenomics Database (CTD),"2-Bromo-4-[(6,7-dimethoxyquinazolin-4-yl)amino]phenol",C113888,WHI P154,https://ctdbase.org/detail.go?type=chem&acc=C113888,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956,EGFR,9606,Homo sapiens (human),WHI P154 results in decreased activity of EGFR protein,,,PMID:11173405,https://www.ncbi.nlm.nih.gov/pubmed/11173405,11173405,,
27,483360,3958,DrugBank,Lorazepam,DB00186,Lorazepam,https://www.drugbank.ca/drugs/DB00186,BE0004797,Gamma-aminobutyric acid receptor subunit theta,https://www.drugbank.ca/bio_entities/BE0004797,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,55879,GABRQ,9606,Homo sapiens (human),Positive allosteric modulator,,,PMID:18384456|PMID:23038269|PMID:29950725,https://www.ncbi.nlm.nih.gov/pubmed/18384456|https://www.ncbi.nlm.nih.gov/pubmed/23038269|https://www.ncbi.nlm.nih.gov/pubmed/29950725,18384456|23038269|29950725,,
28,483361,3958,DrugBank,Lorazepam,DB00186,Lorazepam,https://www.drugbank.ca/drugs/DB00186,BE0008668,Gamma-aminobutyric acid receptor subunit alpha-1,https://www.drugbank.ca/bio_entities/BE0008668,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,2554,GABRA1,9606,Homo sapiens (human),Ligand,,,PMID:29950725|PMID:23038269,https://www.ncbi.nlm.nih.gov/pubmed/29950725|https://www.ncbi.nlm.nih.gov/pubmed/23038269,29950725|23038269,,
29,483362,3958,DrugBank,Lorazepam,DB00186,Lorazepam,https://www.drugbank.ca/drugs/DB00186,BE0008668,Gamma-aminobutyric acid receptor subunit alpha-2,https://www.drugbank.ca/bio_entities/BE0008668,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,2555,GABRA2,9606,Homo sapiens (human),Ligand,,,PMID:29950725|PMID:23038269,https://www.ncbi.nlm.nih.gov/pubmed/29950725|https://www.ncbi.nlm.nih.gov/pubmed/23038269,29950725|23038269,,
30,483363,3958,DrugBank,Lorazepam,DB00186,Lorazepam,https://www.drugbank.ca/drugs/DB00186,BE0008668,Gamma-aminobutyric acid receptor subunit alpha-3,https://www.drugbank.ca/bio_entities/BE0008668,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,2556,GABRA3,9606,Homo sapiens (human),Ligand,,,PMID:29950725|PMID:23038269,https://www.ncbi.nlm.nih.gov/pubmed/29950725|https://www.ncbi.nlm.nih.gov/pubmed/23038269,29950725|23038269,,
31,483364,3958,DrugBank,Lorazepam,DB00186,Lorazepam,https://www.drugbank.ca/drugs/DB00186,BE0008668,Gamma-aminobutyric acid receptor subunit alpha-5,https://www.drugbank.ca/bio_entities/BE0008668,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,2558,GABRA5,9606,Homo sapiens (human),Ligand,,,PMID:29950725|PMID:23038269,https://www.ncbi.nlm.nih.gov/pubmed/29950725|https://www.ncbi.nlm.nih.gov/pubmed/23038269,29950725|23038269,,
32,483365,3958,DrugBank,Lorazepam,DB00186,Lorazepam,https://www.drugbank.ca/drugs/DB00186,BE0008668,Gamma-aminobutyric acid receptor subunit gamma-1,https://www.drugbank.ca/bio_entities/BE0008668,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,2565,GABRG1,9606,Homo sapiens (human),Ligand,,,PMID:29950725|PMID:23038269,https://www.ncbi.nlm.nih.gov/pubmed/29950725|https://www.ncbi.nlm.nih.gov/pubmed/23038269,29950725|23038269,,
33,483366,3958,DrugBank,Lorazepam,DB00186,Lorazepam,https://www.drugbank.ca/drugs/DB00186,BE0008668,Gamma-aminobutyric acid receptor subunit gamma-2,https://www.drugbank.ca/bio_entities/BE0008668,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,2566,GABRG2,9606,Homo sapiens (human),Ligand,,,PMID:29950725|PMID:23038269,https://www.ncbi.nlm.nih.gov/pubmed/29950725|https://www.ncbi.nlm.nih.gov/pubmed/23038269,29950725|23038269,,
34,483367,3958,DrugBank,Lorazepam,DB00186,Lorazepam,https://www.drugbank.ca/drugs/DB00186,BE0008668,Gamma-aminobutyric acid receptor subunit gamma-3,https://www.drugbank.ca/bio_entities/BE0008668,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,2567,GABRG3,9606,Homo sapiens (human),Ligand,,,PMID:29950725|PMID:23038269,https://www.ncbi.nlm.nih.gov/pubmed/29950725|https://www.ncbi.nlm.nih.gov/pubmed/23038269,29950725|23038269,,
35,483368,3958,DrugBank,Lorazepam,DB00186,Lorazepam,https://www.drugbank.ca/drugs/DB00186,BE0004696,UDP-glucuronosyltransferase 2B15,https://www.drugbank.ca/bio_entities/BE0004696,P54855,UDP-glucuronosyltransferase 2B15,7366,UGT2B15,9606,Homo sapiens (human),Substrate,,,PMID:15961980,https://www.ncbi.nlm.nih.gov/pubmed/15961980,15961980,,
36,482673,4100,Comparative Toxicogenomics Database (CTD),Methazolamide,D008704,Methazolamide,https://ctdbase.org/detail.go?type=chem&acc=D008704,2596,GAP43,https://ctdbase.org/detail.go?type=gene&acc=2596,,,2596,GAP43,9606,Homo sapiens (human),Methazolamide affects the expression of GAP43 protein,,,PMID:12388792,https://www.ncbi.nlm.nih.gov/pubmed/12388792,12388792,,
37,482674,4100,Comparative Toxicogenomics Database (CTD),Methazolamide,D008704,Methazolamide,https://ctdbase.org/detail.go?type=chem&acc=D008704,5979,RET,https://ctdbase.org/detail.go?type=gene&acc=5979,,,5979,RET,9606,Homo sapiens (human),Methazolamide affects the expression of RET protein,,,PMID:12388792,https://www.ncbi.nlm.nih.gov/pubmed/12388792,12388792,,
38,482675,4100,Comparative Toxicogenomics Database (CTD),Methazolamide,D008704,Methazolamide,https://ctdbase.org/detail.go?type=chem&acc=D008704,7076,TIMP1,https://ctdbase.org/detail.go?type=gene&acc=7076,,,7076,TIMP1,9606,Homo sapiens (human),Methazolamide affects the expression of TIMP1 protein,,,PMID:12388792,https://www.ncbi.nlm.nih.gov/pubmed/12388792,12388792,,
39,482676,4100,BindingDB,Methazolamide,10881,CHEMBL288100,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10881,1363,Carbonic anhydrase 12,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1363,O43570,Carbonic anhydrase 12,771,CA12,9606,Homo sapiens (human),,Ki (nM),3.4,PMID:18608752|DOI:10.1080/14756360802218441,https://www.ncbi.nlm.nih.gov/pubmed/18608752|https://doi.org/10.1080/14756360802218441,18608752,10.1080/14756360802218441,
40,482677,4100,BindingDB,Methazolamide,10881,CHEMBL288100,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10881,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760,CA2,9606,Homo sapiens (human),,Ki (nM),14.0,PMID:18608752|DOI:10.1080/14756360802218441,https://www.ncbi.nlm.nih.gov/pubmed/18608752|https://doi.org/10.1080/14756360802218441,18608752,10.1080/14756360802218441,
41,483880,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,450076,ARL6IP5A,https://ctdbase.org/detail.go?type=gene&acc=450076,,,450076,arl6ip5a,7955,Danio rerio (zebrafish),Methyl methanesulfonate results in increased expression of ARL6IP5A mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
42,483881,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,127829,ARL8A,https://ctdbase.org/detail.go?type=gene&acc=127829,,,127829,ARL8A,9606,Homo sapiens (human),Methyl methanesulfonate results in increased expression of ARL8A mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
43,484073,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,55207,ARL8B,https://ctdbase.org/detail.go?type=gene&acc=55207,,,55207,ARL8B,9606,Homo sapiens (human),Methyl methanesulfonate results in increased expression of ARL8B mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
44,484561,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,50807,ASAP1,https://ctdbase.org/detail.go?type=gene&acc=50807,,,50807,ASAP1,9606,Homo sapiens (human),Methyl methanesulfonate results in increased expression of ASAP1 mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
45,484562,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,565859,ASAP1B,https://ctdbase.org/detail.go?type=gene&acc=565859,,,565859,asap1b,7955,Danio rerio (zebrafish),Methyl methanesulfonate results in decreased expression of ASAP1B mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
46,484563,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,570669,ASAP2A,https://ctdbase.org/detail.go?type=gene&acc=570669,,,570669,asap2a,7955,Danio rerio (zebrafish),Methyl methanesulfonate results in decreased expression of ASAP2A mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
47,484564,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,560581,ASAP2B,https://ctdbase.org/detail.go?type=gene&acc=560581,,,560581,asap2b,7955,Danio rerio (zebrafish),Methyl methanesulfonate results in decreased expression of ASAP2B mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
48,484565,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,55616,ASAP3,https://ctdbase.org/detail.go?type=gene&acc=55616,,,55616,ASAP3,7955,Danio rerio (zebrafish),Methyl methanesulfonate results in decreased expression of ASAP3 mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
49,484566,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,79754,ASB13,https://ctdbase.org/detail.go?type=gene&acc=79754,,,79754,ASB13,9606,Homo sapiens (human),Methyl methanesulfonate results in decreased expression of ASB13 mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
50,484567,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,556808,ASB13B,https://ctdbase.org/detail.go?type=gene&acc=556808,,,556808,asb13b,7955,Danio rerio (zebrafish),Methyl methanesulfonate results in increased expression of ASB13B mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
51,484568,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,100535284,ASB14B,https://ctdbase.org/detail.go?type=gene&acc=100535284,,,100535284,asb14b,7955,Danio rerio (zebrafish),Methyl methanesulfonate results in increased expression of ASB14B mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
52,483701,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,1993,ELAVL2,https://ctdbase.org/detail.go?type=gene&acc=1993,,,1993,ELAVL2,9606,Homo sapiens (human),Entinostat results in decreased expression of ELAVL2 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
53,483702,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,1995,ELAVL3,https://ctdbase.org/detail.go?type=gene&acc=1995,,,1995,ELAVL3,9606,Homo sapiens (human),Entinostat results in increased expression of ELAVL3 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
54,483703,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,1995,ELAVL3,https://ctdbase.org/detail.go?type=gene&acc=1995,,,1995,ELAVL3,9606,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELAVL3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
55,483704,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,1999,ELF3,https://ctdbase.org/detail.go?type=gene&acc=1999,,,1999,ELF3,9606,Homo sapiens (human),Entinostat results in increased expression of ELF3 mRNA,,,PMID:26272509|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386,26272509|27188386,,
56,483705,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,1999,ELF3,https://ctdbase.org/detail.go?type=gene&acc=1999,,,1999,ELF3,9606,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
57,484388,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,285203,EOGT,https://ctdbase.org/detail.go?type=gene&acc=285203,,,285203,EOGT,9606,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EOGT mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
58,484389,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,100272228,EOLA2-DT,https://ctdbase.org/detail.go?type=gene&acc=100272228,,,100272228,EOLA2-DT,9606,Homo sapiens (human),Entinostat results in decreased expression of EOLA2-DT mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
59,484390,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,100272228,EOLA2-DT,https://ctdbase.org/detail.go?type=gene&acc=100272228,,,100272228,EOLA2-DT,9606,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EOLA2-DT mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
60,484391,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,2033,EP300,https://ctdbase.org/detail.go?type=gene&acc=2033,,,2033,EP300,9606,Homo sapiens (human),Entinostat promotes the reaction [EP300 protein binds to RELA protein],,,PMID:20421217,https://www.ncbi.nlm.nih.gov/pubmed/20421217,20421217,,
61,484392,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,23136,EPB41L3,https://ctdbase.org/detail.go?type=gene&acc=23136,,,23136,EPB41L3,9606,Homo sapiens (human),Entinostat results in increased expression of EPB41L3 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
62,484393,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,23136,EPB41L3,https://ctdbase.org/detail.go?type=gene&acc=23136,,,23136,EPB41L3,9606,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPB41L3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
63,484394,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,54566,EPB41L4B,https://ctdbase.org/detail.go?type=gene&acc=54566,,,54566,EPB41L4B,9606,Homo sapiens (human),Entinostat results in increased expression of EPB41L4B mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
64,481655,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,10572,SIVA1,https://ctdbase.org/detail.go?type=gene&acc=10572,,,10572,SIVA1,10090,Mus musculus (house mouse),Phenobarbital affects the expression of SIVA1 mRNA,,,PMID:23091169,https://www.ncbi.nlm.nih.gov/pubmed/23091169,23091169,,
65,481656,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,6496,SIX3,https://ctdbase.org/detail.go?type=gene&acc=6496,,,6496,SIX3,10090,Mus musculus (house mouse),Phenobarbital affects the methylation of SIX3 gene,,,PMID:19233941,https://www.ncbi.nlm.nih.gov/pubmed/19233941,19233941,,
66,481657,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,51804,SIX4,https://ctdbase.org/detail.go?type=gene&acc=51804,,,51804,SIX4,10090,Mus musculus (house mouse),Phenobarbital results in increased expression of SIX4 mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
67,481658,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,8631,SKAP1,https://ctdbase.org/detail.go?type=gene&acc=8631,,,8631,SKAP1,9606,Homo sapiens (human),Phenobarbital affects the expression of SKAP1 mRNA,,,PMID:19159669,https://www.ncbi.nlm.nih.gov/pubmed/19159669,19159669,,
68,482174,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,441381,LRRC24,https://ctdbase.org/detail.go?type=gene&acc=441381,,,441381,LRRC24,10090,Mus musculus (house mouse),Phenobarbital results in increased expression of LRRC24 mRNA,,,PMID:19482888|PMID:23091169|PMID:33549593,https://www.ncbi.nlm.nih.gov/pubmed/19482888|https://www.ncbi.nlm.nih.gov/pubmed/23091169|https://www.ncbi.nlm.nih.gov/pubmed/33549593,19482888|23091169|33549593,,
69,482175,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,123355,LRRC28,https://ctdbase.org/detail.go?type=gene&acc=123355,,,123355,LRRC28,10090,Mus musculus (house mouse),Phenobarbital affects the expression of LRRC28 mRNA,,,PMID:23091169,https://www.ncbi.nlm.nih.gov/pubmed/23091169,23091169,,
70,482176,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,123355,LRRC28,https://ctdbase.org/detail.go?type=gene&acc=123355,,,123355,LRRC28,10090,Mus musculus (house mouse),Phenobarbital results in increased expression of LRRC28 mRNA,,,PMID:19270015,https://www.ncbi.nlm.nih.gov/pubmed/19270015,19270015,,
71,482177,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,2615,LRRC32,https://ctdbase.org/detail.go?type=gene&acc=2615,,,2615,LRRC32,9606,Homo sapiens (human),Phenobarbital affects the expression of LRRC32 mRNA,,,PMID:19084549,https://www.ncbi.nlm.nih.gov/pubmed/19084549,19084549,,
72,482178,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,127495,LRRC39,https://ctdbase.org/detail.go?type=gene&acc=127495,,,127495,LRRC39,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with phenobarbital] results in increased expression of LRRC39 mRNA,,,PMID:24535843,https://www.ncbi.nlm.nih.gov/pubmed/24535843,24535843,,
73,482179,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,94030,LRRC4B,https://ctdbase.org/detail.go?type=gene&acc=94030,,,94030,LRRC4B,10090,Mus musculus (house mouse),Phenobarbital affects the expression of LRRC4B mRNA,,,PMID:23091169,https://www.ncbi.nlm.nih.gov/pubmed/23091169,23091169,,
74,482180,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,55379,LRRC59,https://ctdbase.org/detail.go?type=gene&acc=55379,,,55379,LRRC59,10116,Rattus norvegicus (Norway rat),Phenobarbital results in increased expression of LRRC59 mRNA,,,PMID:19162173|PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/19162173|https://www.ncbi.nlm.nih.gov/pubmed/30047161,19162173|30047161,,
75,482181,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,56262,LRRC8A,https://ctdbase.org/detail.go?type=gene&acc=56262,,,56262,LRRC8A,10090,Mus musculus (house mouse),Phenobarbital results in decreased expression of LRRC8A mRNA,,,PMID:19270015,https://www.ncbi.nlm.nih.gov/pubmed/19270015,19270015,,
76,482182,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,84230,LRRC8C,https://ctdbase.org/detail.go?type=gene&acc=84230,,,84230,LRRC8C,9606,Homo sapiens (human),Phenobarbital results in increased expression of LRRC8C mRNA,,,PMID:19084549,https://www.ncbi.nlm.nih.gov/pubmed/19084549,19084549,,
77,482332,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,347731,LRRTM3,https://ctdbase.org/detail.go?type=gene&acc=347731,,,347731,LRRTM3,9606,Homo sapiens (human),Phenobarbital results in decreased expression of LRRTM3 mRNA,,,PMID:19084549,https://www.ncbi.nlm.nih.gov/pubmed/19084549,19084549,,
78,483012,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,256394,SERPINA11,https://ctdbase.org/detail.go?type=gene&acc=256394,,,256394,SERPINA11,10090,Mus musculus (house mouse),Phenobarbital affects the expression of SERPINA11 mRNA,,,PMID:23091169,https://www.ncbi.nlm.nih.gov/pubmed/23091169,23091169,,
79,483013,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,145264,SERPINA12,https://ctdbase.org/detail.go?type=gene&acc=145264,,,145264,SERPINA12,10090,Mus musculus (house mouse),NR1I3 protein affects the reaction [phenobarbital results in decreased expression of SERPINA12 mrna],,,PMID:19482888,https://www.ncbi.nlm.nih.gov/pubmed/19482888,19482888,,
80,483014,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,145264,SERPINA12,https://ctdbase.org/detail.go?type=gene&acc=145264,,,145264,SERPINA12,10090,Mus musculus (house mouse),Phenobarbital results in decreased expression of SERPINA12 mRNA,,,PMID:19482888|PMID:23091169,https://www.ncbi.nlm.nih.gov/pubmed/19482888|https://www.ncbi.nlm.nih.gov/pubmed/23091169,19482888|23091169,,
81,483015,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,20715,SERPINA3G,https://ctdbase.org/detail.go?type=gene&acc=20715,,,20715,Serpina3g,10090,Mus musculus (house mouse),Phenobarbital results in decreased expression of SERPINA3G mrna|nr1i3 protein affects the reaction [phenobarbital results in decreased expression of SERPINA3G mrna],,,PMID:19482888,https://www.ncbi.nlm.nih.gov/pubmed/19482888,19482888,,
82,483016,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,20714,SERPINA3K,https://ctdbase.org/detail.go?type=gene&acc=20714,,,20714,Serpina3k,10090,Mus musculus (house mouse),NR1I3 protein promotes the reaction [phenobarbital results in decreased expression of SERPINA3K mrna],,,PMID:19850644,https://www.ncbi.nlm.nih.gov/pubmed/19850644,19850644,,
83,483017,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,20714,SERPINA3K,https://ctdbase.org/detail.go?type=gene&acc=20714,,,20714,Serpina3k,10090,Mus musculus (house mouse),Phenobarbital affects the expression of SERPINA3K mRNA,,,PMID:19136022,https://www.ncbi.nlm.nih.gov/pubmed/19136022,19136022,,
84,483018,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,20714,SERPINA3K,https://ctdbase.org/detail.go?type=gene&acc=20714,,,20714,Serpina3k,10090,Mus musculus (house mouse),Phenobarbital results in decreased expression of SERPINA3K mRNA,,,PMID:19850644|PMID:23091169,https://www.ncbi.nlm.nih.gov/pubmed/19850644|https://www.ncbi.nlm.nih.gov/pubmed/23091169,19850644|23091169,,
85,483019,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,321018,SERPINA4-PS1,https://ctdbase.org/detail.go?type=gene&acc=321018,,,321018,Serpina4-ps1,10090,Mus musculus (house mouse),NR1I3 protein affects the reaction [phenobarbital results in decreased expression of SERPINA4-PS1 mrna],,,PMID:19482888,https://www.ncbi.nlm.nih.gov/pubmed/19482888,19482888,,
86,483020,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,321018,SERPINA4-PS1,https://ctdbase.org/detail.go?type=gene&acc=321018,,,321018,Serpina4-ps1,10090,Mus musculus (house mouse),Phenobarbital affects the expression of SERPINA4-PS1 mRNA,,,PMID:19136022|PMID:23091169,https://www.ncbi.nlm.nih.gov/pubmed/19136022|https://www.ncbi.nlm.nih.gov/pubmed/23091169,19136022|23091169,,
87,483021,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,321018,SERPINA4-PS1,https://ctdbase.org/detail.go?type=gene&acc=321018,,,321018,Serpina4-ps1,10090,Mus musculus (house mouse),Phenobarbital results in decreased expression of SERPINA4-PS1 mRNA,,,PMID:19270015|PMID:19482888,https://www.ncbi.nlm.nih.gov/pubmed/19270015|https://www.ncbi.nlm.nih.gov/pubmed/19482888,19270015|19482888,,
88,483164,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,9963,SLC23A1,https://ctdbase.org/detail.go?type=gene&acc=9963,,,9963,SLC23A1,10090,Mus musculus (house mouse),Phenobarbital results in increased expression of SLC23A1 mRNA,,,PMID:19270015,https://www.ncbi.nlm.nih.gov/pubmed/19270015,19270015,,
89,483165,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,9962,SLC23A2,https://ctdbase.org/detail.go?type=gene&acc=9962,,,9962,SLC23A2,10090,Mus musculus (house mouse),Phenobarbital results in increased expression of SLC23A2 mRNA,,,PMID:23091169,https://www.ncbi.nlm.nih.gov/pubmed/23091169,23091169,,
90,483166,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,10166,SLC25A15,https://ctdbase.org/detail.go?type=gene&acc=10166,,,10166,SLC25A15,10090,Mus musculus (house mouse),Phenobarbital results in increased expression of SLC25A15 mRNA,,,PMID:19270015,https://www.ncbi.nlm.nih.gov/pubmed/19270015,19270015,,
91,556046,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,57530,CGN,https://ctdbase.org/detail.go?type=gene&acc=57530,,,57530,CGN,9606,Homo sapiens (human),Phenobarbital affects the expression of CGN mRNA,,,PMID:19159669,https://www.ncbi.nlm.nih.gov/pubmed/19159669,19159669,,
92,556047,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,57530,CGN,https://ctdbase.org/detail.go?type=gene&acc=57530,,,57530,CGN,9606,Homo sapiens (human),Phenobarbital results in decreased expression of CGN mRNA,,,PMID:19084549,https://www.ncbi.nlm.nih.gov/pubmed/19084549,19084549,,
93,556048,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,57530,CGN,https://ctdbase.org/detail.go?type=gene&acc=57530,,,57530,CGN,10090,Mus musculus (house mouse),Phenobarbital results in decreased expression of CGN mRNA,,,PMID:19270015,https://www.ncbi.nlm.nih.gov/pubmed/19270015,19270015,,
94,556049,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,10668,CGRRF1,https://ctdbase.org/detail.go?type=gene&acc=10668,,,10668,CGRRF1,9606,Homo sapiens (human),Phenobarbital affects the expression of CGRRF1 mRNA,,,PMID:19159669,https://www.ncbi.nlm.nih.gov/pubmed/19159669,19159669,,
95,556050,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,79094,CHAC1,https://ctdbase.org/detail.go?type=gene&acc=79094,,,79094,CHAC1,10090,Mus musculus (house mouse),NR1I3 protein affects the reaction [phenobarbital results in increased expression of CHAC1 mrna]|phenobarbital results in increased expression of CHAC1 mRNA,,,PMID:19482888,https://www.ncbi.nlm.nih.gov/pubmed/19482888,19482888,,
96,556051,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,79094,CHAC1,https://ctdbase.org/detail.go?type=gene&acc=79094,,,79094,CHAC1,10090,Mus musculus (house mouse),Phenobarbital results in decreased expression of CHAC1 mRNA,,,PMID:19270015|PMID:23091169,https://www.ncbi.nlm.nih.gov/pubmed/19270015|https://www.ncbi.nlm.nih.gov/pubmed/23091169,19270015|23091169,,
97,483882,5235,Comparative Toxicogenomics Database (CTD),Sodium Fluoride,D012969,Sodium Fluoride,https://ctdbase.org/detail.go?type=chem&acc=D012969,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277,COL1A1,10116,Rattus norvegicus (Norway rat),Sodium fluoride results in decreased expression of COL1A1 mRNA,,,PMID:21093551,https://www.ncbi.nlm.nih.gov/pubmed/21093551,21093551,,
98,483883,5235,Comparative Toxicogenomics Database (CTD),Sodium Fluoride,D012969,Sodium Fluoride,https://ctdbase.org/detail.go?type=chem&acc=D012969,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277,COL1A1,10116,Rattus norvegicus (Norway rat),Sodium fluoride results in increased expression of COL1A1 mRNA,,,PMID:24300170|PMID:29758312,https://www.ncbi.nlm.nih.gov/pubmed/24300170|https://www.ncbi.nlm.nih.gov/pubmed/29758312,24300170|29758312,,
99,483884,5235,Comparative Toxicogenomics Database (CTD),Sodium Fluoride,D012969,Sodium Fluoride,https://ctdbase.org/detail.go?type=chem&acc=D012969,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277,COL1A1,10116,Rattus norvegicus (Norway rat),Sodium fluoride results in increased expression of COL1A1 protein,,,PMID:29653260,https://www.ncbi.nlm.nih.gov/pubmed/29653260,29653260,,
100,483885,5235,Comparative Toxicogenomics Database (CTD),Sodium Fluoride,D012969,Sodium Fluoride,https://ctdbase.org/detail.go?type=chem&acc=D012969,169044,COL22A1,https://ctdbase.org/detail.go?type=gene&acc=169044,,,169044,COL22A1,10090,Mus musculus (house mouse),Sodium fluoride results in increased expression of COL22A1 protein,,,PMID:28918527,https://www.ncbi.nlm.nih.gov/pubmed/28918527,28918527,,
101,483886,5235,Comparative Toxicogenomics Database (CTD),Sodium Fluoride,D012969,Sodium Fluoride,https://ctdbase.org/detail.go?type=chem&acc=D012969,1280,COL2A1,https://ctdbase.org/detail.go?type=gene&acc=1280,,,1280,COL2A1,10090,Mus musculus (house mouse),"4,6-dimorpholino-N-(4-nitrophenyl)-1,3,5-triazin-2-amine inhibits the reaction [sodium fluoride results in decreased expression of COL2A1 protein]|sodium fluoride results in decreased expression of COL2A1 mrna|4,6-dimorpholino-N-(4-nitrophenyl)-1,3,5-triazin-2-amine inhibits the reaction [sodium fluoride results in decreased expression of COL2A1 mrna]|sodium fluoride results in decreased expression of COL2A1 protein",,,PMID:34536393,https://www.ncbi.nlm.nih.gov/pubmed/34536393,34536393,,
102,483887,5235,Comparative Toxicogenomics Database (CTD),Sodium Fluoride,D012969,Sodium Fluoride,https://ctdbase.org/detail.go?type=chem&acc=D012969,1290,COL5A2,https://ctdbase.org/detail.go?type=gene&acc=1290,,,1290,COL5A2,10090,Mus musculus (house mouse),Sodium fluoride results in decreased expression of COL5A2 protein,,,PMID:28918527,https://www.ncbi.nlm.nih.gov/pubmed/28918527,28918527,,
103,483888,5235,Comparative Toxicogenomics Database (CTD),Sodium Fluoride,D012969,Sodium Fluoride,https://ctdbase.org/detail.go?type=chem&acc=D012969,1291,COL6A1,https://ctdbase.org/detail.go?type=gene&acc=1291,,,1291,COL6A1,10090,Mus musculus (house mouse),Sodium fluoride results in decreased expression of COL6A1 protein,,,PMID:28918527,https://www.ncbi.nlm.nih.gov/pubmed/28918527,28918527,,
104,484569,5235,Comparative Toxicogenomics Database (CTD),Sodium Fluoride,D012969,Sodium Fluoride,https://ctdbase.org/detail.go?type=chem&acc=D012969,1349,COX7B,https://ctdbase.org/detail.go?type=gene&acc=1349,,,1349,COX7B,10090,Mus musculus (house mouse),Sodium fluoride results in decreased expression of COX7B mRNA,,,PMID:27862939,https://www.ncbi.nlm.nih.gov/pubmed/27862939,27862939,,
105,555732,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,2734,GLG1,https://ctdbase.org/detail.go?type=gene&acc=2734,,,2734,GLG1,9606,Homo sapiens (human),Vorinostat results in decreased expression of GLG1 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
106,555733,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,11010,GLIPR1,https://ctdbase.org/detail.go?type=gene&acc=11010,,,11010,GLIPR1,9606,Homo sapiens (human),Vorinostat results in increased expression of GLIPR1 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
107,555734,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,2743,GLRB,https://ctdbase.org/detail.go?type=gene&acc=2743,,,2743,GLRB,9606,Homo sapiens (human),Vorinostat results in increased expression of GLRB mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
108,482173,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,55973,BCAP29,https://ctdbase.org/detail.go?type=gene&acc=55973,,,55973,BCAP29,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in increased expression of BCAP29 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
109,482527,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,27319,BHLHE22,https://ctdbase.org/detail.go?type=gene&acc=27319,,,27319,BHLHE22,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in decreased expression of BHLHE22 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
110,482528,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,635,BHMT,https://ctdbase.org/detail.go?type=gene&acc=635,,,635,BHMT,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in decreased expression of BHMT mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
111,482529,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,636,BICD1,https://ctdbase.org/detail.go?type=gene&acc=636,,,636,BICD1,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in decreased expression of BICD1 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
112,484749,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,8814,CDKL1,https://ctdbase.org/detail.go?type=gene&acc=8814,,,8814,CDKL1,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in decreased expression of CDKL1 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
113,484750,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026,CDKN1A,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in increased expression of CDKN1A protein,,,PMID:23535288,https://www.ncbi.nlm.nih.gov/pubmed/23535288,23535288,,
114,484751,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,1030,CDKN2B,https://ctdbase.org/detail.go?type=gene&acc=1030,,,1030,CDKN2B,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in increased expression of CDKN2B mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
115,484752,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,1044,CDX1,https://ctdbase.org/detail.go?type=gene&acc=1044,,,1044,CDX1,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in decreased expression of CDX1 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
116,482023,5382,Comparative Toxicogenomics Database (CTD),Tcpobop,C028474,"1,4-bis(2-(3,5-dichloropyridyloxy))benzene",https://ctdbase.org/detail.go?type=chem&acc=C028474,1647,GADD45A,https://ctdbase.org/detail.go?type=gene&acc=1647,,,1647,GADD45A,10090,Mus musculus (house mouse),"1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of GADD45A mRNA",,,PMID:21354444|PMID:22698814|PMID:23626729|PMID:28903501,https://www.ncbi.nlm.nih.gov/pubmed/21354444|https://www.ncbi.nlm.nih.gov/pubmed/22698814|https://www.ncbi.nlm.nih.gov/pubmed/23626729|https://www.ncbi.nlm.nih.gov/pubmed/28903501,21354444|22698814|23626729|28903501,,
117,482024,5382,Comparative Toxicogenomics Database (CTD),Tcpobop,C028474,"1,4-bis(2-(3,5-dichloropyridyloxy))benzene",https://ctdbase.org/detail.go?type=chem&acc=C028474,4616,GADD45B,https://ctdbase.org/detail.go?type=gene&acc=4616,,,4616,GADD45B,10090,Mus musculus (house mouse),"1,4-bis(2-(3,5-dichloropyridyloxy))benzene affects the expression of GADD45B protein",,,PMID:32123963,https://www.ncbi.nlm.nih.gov/pubmed/32123963,32123963,,
118,482025,5382,Comparative Toxicogenomics Database (CTD),Tcpobop,C028474,"1,4-bis(2-(3,5-dichloropyridyloxy))benzene",https://ctdbase.org/detail.go?type=chem&acc=C028474,4616,GADD45B,https://ctdbase.org/detail.go?type=gene&acc=4616,,,4616,GADD45B,10090,Mus musculus (house mouse),"1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of GADD45B protein|1,4-bis(2-(3,5-dichloropyridyloxy))benzene promotes the reaction [GADD45B protein binds to CYP2B10 promoter]",,,PMID:23684557,https://www.ncbi.nlm.nih.gov/pubmed/23684557,23684557,,
119,482026,5382,Comparative Toxicogenomics Database (CTD),Tcpobop,C028474,"1,4-bis(2-(3,5-dichloropyridyloxy))benzene",https://ctdbase.org/detail.go?type=chem&acc=C028474,4616,GADD45B,https://ctdbase.org/detail.go?type=gene&acc=4616,,,4616,GADD45B,10090,Mus musculus (house mouse),"1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of GADD45B mRNA",,,PMID:19850644|PMID:21354444|PMID:22698814|PMID:23684557|PMID:28903501|PMID:29244179|PMID:31170421,https://www.ncbi.nlm.nih.gov/pubmed/19850644|https://www.ncbi.nlm.nih.gov/pubmed/21354444|https://www.ncbi.nlm.nih.gov/pubmed/22698814|https://www.ncbi.nlm.nih.gov/pubmed/23684557|https://www.ncbi.nlm.nih.gov/pubmed/28903501|https://www.ncbi.nlm.nih.gov/pubmed/29244179|https://www.ncbi.nlm.nih.gov/pubmed/31170421,19850644|21354444|22698814|23684557|28903501|29244179|31170421,,
120,482027,5382,Comparative Toxicogenomics Database (CTD),Tcpobop,C028474,"1,4-bis(2-(3,5-dichloropyridyloxy))benzene",https://ctdbase.org/detail.go?type=chem&acc=C028474,4616,GADD45B,https://ctdbase.org/detail.go?type=gene&acc=4616,,,4616,GADD45B,10090,Mus musculus (house mouse),"NR1I3 protein promotes the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of GADD45B mrna]",,,PMID:19850644|PMID:22698814,https://www.ncbi.nlm.nih.gov/pubmed/19850644|https://www.ncbi.nlm.nih.gov/pubmed/22698814,19850644|22698814,,
121,482028,5382,Comparative Toxicogenomics Database (CTD),Tcpobop,C028474,"1,4-bis(2-(3,5-dichloropyridyloxy))benzene",https://ctdbase.org/detail.go?type=chem&acc=C028474,10912,GADD45G,https://ctdbase.org/detail.go?type=gene&acc=10912,,,10912,GADD45G,10090,Mus musculus (house mouse),"1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in decreased expression of GADD45G mRNA",,,PMID:28903501,https://www.ncbi.nlm.nih.gov/pubmed/28903501,28903501,,
122,482029,5382,Comparative Toxicogenomics Database (CTD),Tcpobop,C028474,"1,4-bis(2-(3,5-dichloropyridyloxy))benzene",https://ctdbase.org/detail.go?type=chem&acc=C028474,10912,GADD45G,https://ctdbase.org/detail.go?type=gene&acc=10912,,,10912,GADD45G,10090,Mus musculus (house mouse),"1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of GADD45G mRNA",,,PMID:21354444,https://www.ncbi.nlm.nih.gov/pubmed/21354444,21354444,,
123,482030,5382,Comparative Toxicogenomics Database (CTD),Tcpobop,C028474,"1,4-bis(2-(3,5-dichloropyridyloxy))benzene",https://ctdbase.org/detail.go?type=chem&acc=C028474,2582,GALE,https://ctdbase.org/detail.go?type=gene&acc=2582,,,2582,GALE,10090,Mus musculus (house mouse),"1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in decreased expression of GALE mRNA",,,PMID:28903501,https://www.ncbi.nlm.nih.gov/pubmed/28903501,28903501,,
124,482031,5382,Comparative Toxicogenomics Database (CTD),Tcpobop,C028474,"1,4-bis(2-(3,5-dichloropyridyloxy))benzene",https://ctdbase.org/detail.go?type=chem&acc=C028474,2593,GAMT,https://ctdbase.org/detail.go?type=gene&acc=2593,,,2593,GAMT,10090,Mus musculus (house mouse),"1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in decreased expression of GAMT mRNA",,,PMID:22698814|PMID:28903501,https://www.ncbi.nlm.nih.gov/pubmed/22698814|https://www.ncbi.nlm.nih.gov/pubmed/28903501,22698814|28903501,,
125,482861,5382,Comparative Toxicogenomics Database (CTD),Tcpobop,C028474,"1,4-bis(2-(3,5-dichloropyridyloxy))benzene",https://ctdbase.org/detail.go?type=chem&acc=C028474,2752,GLUL,https://ctdbase.org/detail.go?type=gene&acc=2752,,,2752,GLUL,10090,Mus musculus (house mouse),"GLUL protein affects the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in decreased expression of CTNNB1 protein modified form]|ctnnb1 gene mutant form affects the susceptibility to [1,4-bis(2-(3,5-dichloropyridyloxy))benzene affects the expression of GLUL protein]",,,PMID:21705713,https://www.ncbi.nlm.nih.gov/pubmed/21705713,21705713,,
126,482862,5382,Comparative Toxicogenomics Database (CTD),Tcpobop,C028474,"1,4-bis(2-(3,5-dichloropyridyloxy))benzene",https://ctdbase.org/detail.go?type=chem&acc=C028474,10249,GLYAT,https://ctdbase.org/detail.go?type=gene&acc=10249,,,10249,GLYAT,10090,Mus musculus (house mouse),"1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of GLYAT mRNA",,,PMID:27413110,https://www.ncbi.nlm.nih.gov/pubmed/27413110,27413110,,
127,482863,5382,Comparative Toxicogenomics Database (CTD),Tcpobop,C028474,"1,4-bis(2-(3,5-dichloropyridyloxy))benzene",https://ctdbase.org/detail.go?type=chem&acc=C028474,2760,GM2A,https://ctdbase.org/detail.go?type=gene&acc=2760,,,2760,GM2A,10090,Mus musculus (house mouse),"1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of GM2A mRNA",,,PMID:28903501,https://www.ncbi.nlm.nih.gov/pubmed/28903501,28903501,,
128,482864,5382,Comparative Toxicogenomics Database (CTD),Tcpobop,C028474,"1,4-bis(2-(3,5-dichloropyridyloxy))benzene",https://ctdbase.org/detail.go?type=chem&acc=C028474,51053,GMNN,https://ctdbase.org/detail.go?type=gene&acc=51053,,,51053,GMNN,10090,Mus musculus (house mouse),"1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of GMNN mRNA",,,PMID:22698814,https://www.ncbi.nlm.nih.gov/pubmed/22698814,22698814,,
129,482865,5382,Comparative Toxicogenomics Database (CTD),Tcpobop,C028474,"1,4-bis(2-(3,5-dichloropyridyloxy))benzene",https://ctdbase.org/detail.go?type=chem&acc=C028474,9630,GNA14,https://ctdbase.org/detail.go?type=gene&acc=9630,,,9630,GNA14,10090,Mus musculus (house mouse),"1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of GNA14 mRNA",,,PMID:21354444|PMID:22698814|PMID:27413110|PMID:28903501,https://www.ncbi.nlm.nih.gov/pubmed/21354444|https://www.ncbi.nlm.nih.gov/pubmed/22698814|https://www.ncbi.nlm.nih.gov/pubmed/27413110|https://www.ncbi.nlm.nih.gov/pubmed/28903501,21354444|22698814|27413110|28903501,,
130,482866,5382,Comparative Toxicogenomics Database (CTD),Tcpobop,C028474,"1,4-bis(2-(3,5-dichloropyridyloxy))benzene",https://ctdbase.org/detail.go?type=chem&acc=C028474,9630,GNA14,https://ctdbase.org/detail.go?type=gene&acc=9630,,,9630,GNA14,10090,Mus musculus (house mouse),"NR1I3 protein promotes the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of GNA14 mrna]",,,PMID:22698814,https://www.ncbi.nlm.nih.gov/pubmed/22698814,22698814,,
131,482867,5382,Comparative Toxicogenomics Database (CTD),Tcpobop,C028474,"1,4-bis(2-(3,5-dichloropyridyloxy))benzene",https://ctdbase.org/detail.go?type=chem&acc=C028474,2779,GNAT1,https://ctdbase.org/detail.go?type=gene&acc=2779,,,2779,GNAT1,10090,Mus musculus (house mouse),"1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in decreased expression of GNAT1 mRNA",,,PMID:28903501,https://www.ncbi.nlm.nih.gov/pubmed/28903501,28903501,,
132,482521,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,1230,CCR1,https://ctdbase.org/detail.go?type=gene&acc=1230,,,1230,CCR1,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of CCR1 mRNA,,,PMID:20813756,https://www.ncbi.nlm.nih.gov/pubmed/20813756,20813756,,
133,482522,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,1233,CCR4,https://ctdbase.org/detail.go?type=gene&acc=1233,,,1233,CCR4,10090,Mus musculus (house mouse),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CCR4 mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
134,482523,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,1234,CCR5,https://ctdbase.org/detail.go?type=gene&acc=1234,,,1234,CCR5,10090,Mus musculus (house mouse),Pirinixic acid inhibits the reaction [cisplatin results in increased expression of CCR5 mrna],,,PMID:15814532,https://www.ncbi.nlm.nih.gov/pubmed/15814532,15814532,,
135,482524,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,1236,CCR7,https://ctdbase.org/detail.go?type=gene&acc=1236,,,1236,CCR7,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of CCR7 mRNA,,,PMID:20813756,https://www.ncbi.nlm.nih.gov/pubmed/20813756,20813756,,
136,482525,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,9973,CCS,https://ctdbase.org/detail.go?type=gene&acc=9973,,,9973,CCS,9606,Homo sapiens (human),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CCS mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
137,482526,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,9973,CCS,https://ctdbase.org/detail.go?type=gene&acc=9973,,,9973,CCS,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of CCS mRNA,,,PMID:17426115|PMID:18301758,https://www.ncbi.nlm.nih.gov/pubmed/17426115|https://www.ncbi.nlm.nih.gov/pubmed/18301758,17426115|18301758,,
138,483524,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,4709,NDUFB3,https://ctdbase.org/detail.go?type=gene&acc=4709,,,4709,NDUFB3,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of NDUFB3 mRNA,,,PMID:18301758|PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/18301758|https://www.ncbi.nlm.nih.gov/pubmed/23811191,18301758|23811191,,
139,483525,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,4713,NDUFB7,https://ctdbase.org/detail.go?type=gene&acc=4713,,,4713,NDUFB7,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of NDUFB7 mRNA,,,PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/23811191,23811191,,
140,483526,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,4717,NDUFC1,https://ctdbase.org/detail.go?type=gene&acc=4717,,,4717,NDUFC1,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of NDUFC1 mRNA,,,PMID:18301758|PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/18301758|https://www.ncbi.nlm.nih.gov/pubmed/23811191,18301758|23811191,,
141,483527,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,4719,NDUFS1,https://ctdbase.org/detail.go?type=gene&acc=4719,,,4719,NDUFS1,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of NDUFS1 mRNA,,,PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/23811191,23811191,,
142,483528,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,4784,NFIX,https://ctdbase.org/detail.go?type=gene&acc=4784,,,4784,NFIX,10090,Mus musculus (house mouse),PPARA protein promotes the reaction [pirinixic acid results in decreased expression of NFIX mrna],,,PMID:20059764,https://www.ncbi.nlm.nih.gov/pubmed/20059764,20059764,,
143,483529,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,4724,NDUFS4,https://ctdbase.org/detail.go?type=gene&acc=4724,,,4724,NDUFS4,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of NDUFS4 mRNA,,,PMID:17426115|PMID:18301758|PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/17426115|https://www.ncbi.nlm.nih.gov/pubmed/18301758|https://www.ncbi.nlm.nih.gov/pubmed/23811191,17426115|18301758|23811191,,
144,483530,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,4725,NDUFS5,https://ctdbase.org/detail.go?type=gene&acc=4725,,,4725,NDUFS5,10116,Rattus norvegicus (Norway rat),Pirinixic acid affects the expression of NDUFS5 mRNA,,,PMID:19483382,https://www.ncbi.nlm.nih.gov/pubmed/19483382,19483382,,
145,483531,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,4731,NDUFV3,https://ctdbase.org/detail.go?type=gene&acc=4731,,,4731,NDUFV3,10090,Mus musculus (house mouse),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NDUFV3 mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
146,483532,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,4731,NDUFV3,https://ctdbase.org/detail.go?type=gene&acc=4731,,,4731,NDUFV3,10116,Rattus norvegicus (Norway rat),Pirinixic acid affects the expression of NDUFV3 mRNA,,,PMID:19483382,https://www.ncbi.nlm.nih.gov/pubmed/19483382,19483382,,
147,484065,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,23327,NEDD4L,https://ctdbase.org/detail.go?type=gene&acc=23327,,,23327,NEDD4L,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of NEDD4L mRNA,,,PMID:18301758|PMID:18445702,https://www.ncbi.nlm.nih.gov/pubmed/18301758|https://www.ncbi.nlm.nih.gov/pubmed/18445702,18301758|18445702,,
148,484066,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,4738,NEDD8,https://ctdbase.org/detail.go?type=gene&acc=4738,,,4738,NEDD8,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of NEDD8 mRNA,,,PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/23811191,23811191,,
149,484067,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,4739,NEDD9,https://ctdbase.org/detail.go?type=gene&acc=4739,,,4739,NEDD9,10090,Mus musculus (house mouse),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NEDD9 mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
150,484068,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,4744,NEFH,https://ctdbase.org/detail.go?type=gene&acc=4744,,,4744,NEFH,9606,Homo sapiens (human),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NEFH mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
151,484069,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,4750,NEK1,https://ctdbase.org/detail.go?type=gene&acc=4750,,,4750,NEK1,10090,Mus musculus (house mouse),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NEK1 mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
152,484070,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,4750,NEK1,https://ctdbase.org/detail.go?type=gene&acc=4750,,,4750,NEK1,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of NEK1 mRNA,,,PMID:18301758,https://www.ncbi.nlm.nih.gov/pubmed/18301758,18301758,,
153,484071,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,4751,NEK2,https://ctdbase.org/detail.go?type=gene&acc=4751,,,4751,NEK2,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of NEK2 mRNA,,,PMID:17950772|PMID:18301758|PMID:20813756|PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/17950772|https://www.ncbi.nlm.nih.gov/pubmed/18301758|https://www.ncbi.nlm.nih.gov/pubmed/20813756|https://www.ncbi.nlm.nih.gov/pubmed/23811191,17950772|18301758|20813756|23811191,,
154,484072,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,4751,NEK2,https://ctdbase.org/detail.go?type=gene&acc=4751,,,4751,NEK2,10090,Mus musculus (house mouse),PPARA protein promotes the reaction [pirinixic acid results in increased expression of NEK2 mrna],,,PMID:17950772,https://www.ncbi.nlm.nih.gov/pubmed/17950772,17950772,,
155,555735,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,6102,RP2,https://ctdbase.org/detail.go?type=gene&acc=6102,,,6102,RP2,10090,Mus musculus (house mouse),Pirinixic acid results in decreased expression of RP2 mRNA,,,PMID:18445702,https://www.ncbi.nlm.nih.gov/pubmed/18445702,18445702,,
156,555878,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,5340,PLG,https://ctdbase.org/detail.go?type=gene&acc=5340,,,5340,PLG,10090,Mus musculus (house mouse),[pirinixic acid co-treated with PPARA] results in decreased expression of PLG mrna|pirinixic acid results in decreased expression of PLG mRNA,,,PMID:20813756,https://www.ncbi.nlm.nih.gov/pubmed/20813756,20813756,,
157,555879,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,5340,PLG,https://ctdbase.org/detail.go?type=gene&acc=5340,,,5340,PLG,10116,Rattus norvegicus (Norway rat),Pirinixic acid affects the expression of PLG mRNA,,,PMID:19483382,https://www.ncbi.nlm.nih.gov/pubmed/19483382,19483382,,
158,555880,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,123,PLIN2,https://ctdbase.org/detail.go?type=gene&acc=123,,,123,PLIN2,9606,Homo sapiens (human),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PLIN2 mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
159,555881,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,123,PLIN2,https://ctdbase.org/detail.go?type=gene&acc=123,,,123,PLIN2,9606,Homo sapiens (human),Pirinixic acid results in increased expression of PLIN2 mRNA,,,PMID:18518955|PMID:23811191|PMID:31676336,https://www.ncbi.nlm.nih.gov/pubmed/18518955|https://www.ncbi.nlm.nih.gov/pubmed/23811191|https://www.ncbi.nlm.nih.gov/pubmed/31676336,18518955|23811191|31676336,,
160,555882,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,123,PLIN2,https://ctdbase.org/detail.go?type=gene&acc=123,,,123,PLIN2,10090,Mus musculus (house mouse),[pirinixic acid co-treated with PPARA] results in increased expression of PLIN2 mRNA,,,PMID:20813756,https://www.ncbi.nlm.nih.gov/pubmed/20813756,20813756,,
161,555883,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,57047,PLSCR2,https://ctdbase.org/detail.go?type=gene&acc=57047,,,57047,PLSCR2,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of PLSCR2 mRNA,,,PMID:17426115,https://www.ncbi.nlm.nih.gov/pubmed/17426115,17426115,,
162,555884,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,123,PLIN2,https://ctdbase.org/detail.go?type=gene&acc=123,,,123,PLIN2,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of PLIN2 mRNA,,,PMID:16221962|PMID:16282640|PMID:16489205|PMID:17426115|PMID:17932310|PMID:18301758|PMID:18445702|PMID:20059764|PMID:20813756|PMID:23811191|PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/16221962|https://www.ncbi.nlm.nih.gov/pubmed/16282640|https://www.ncbi.nlm.nih.gov/pubmed/16489205|https://www.ncbi.nlm.nih.gov/pubmed/17426115|https://www.ncbi.nlm.nih.gov/pubmed/17932310|https://www.ncbi.nlm.nih.gov/pubmed/18301758|https://www.ncbi.nlm.nih.gov/pubmed/18445702|https://www.ncbi.nlm.nih.gov/pubmed/20059764|https://www.ncbi.nlm.nih.gov/pubmed/20813756|https://www.ncbi.nlm.nih.gov/pubmed/23811191|https://www.ncbi.nlm.nih.gov/pubmed/25270620,16221962|16282640|16489205|17426115|17932310|18301758|18445702|20059764|20813756|23811191|25270620,,
163,556052,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,81693,AMN,https://ctdbase.org/detail.go?type=gene&acc=81693,,,81693,AMN,8090,Oryzias latipes (Japanese medaka),Estradiol results in decreased expression of AMN mRNA,,,PMID:32622090,https://www.ncbi.nlm.nih.gov/pubmed/32622090,32622090,,
164,556053,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,154796,AMOT,https://ctdbase.org/detail.go?type=gene&acc=154796,,,154796,AMOT,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in decreased expression of AMOT mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
165,556054,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,154796,AMOT,https://ctdbase.org/detail.go?type=gene&acc=154796,,,154796,AMOT,9606,Homo sapiens (human),Estradiol results in decreased expression of AMOT mRNA,,,PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/31614463,31614463,,
166,556055,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,154796,AMOT,https://ctdbase.org/detail.go?type=gene&acc=154796,,,154796,AMOT,10116,Rattus norvegicus (Norway rat),Estradiol affects the expression of AMOT mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
167,556056,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,154810,AMOTL1,https://ctdbase.org/detail.go?type=gene&acc=154810,,,154810,AMOTL1,9606,Homo sapiens (human),Estradiol affects the expression of AMOTL1 mRNA,,,PMID:22574217,https://www.ncbi.nlm.nih.gov/pubmed/22574217,22574217,,
168,556208,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004967,Estrogens,https://ctdbase.org/detail.go?type=chem&acc=D004967,3606,IL18,https://ctdbase.org/detail.go?type=gene&acc=3606,,,3606,IL18,10090,Mus musculus (house mouse),Estrogens inhibits the reaction [lipopolysaccharides results in increased expression of IL18 mrna]|[progesterone co-treated with estrogens] inhibits the reaction [lipopolysaccharides results in increased expression of IL18 mrna]|[fulvestrant co-treated with mifepristone] inhibits the reaction [[progesterone co-treated with estrogens] inhibits the reaction [lipopolysaccharides results in increased expression of IL18 mrna]],,,PMID:17850464,https://www.ncbi.nlm.nih.gov/pubmed/17850464,17850464,,
169,556209,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004967,Estrogens,https://ctdbase.org/detail.go?type=chem&acc=D004967,3552,IL1A,https://ctdbase.org/detail.go?type=gene&acc=3552,,,3552,IL1A,10090,Mus musculus (house mouse),"Drugs, chinese herbal inhibits the reaction [estrogens results in increased expression of IL1A]",,,PMID:14758024,https://www.ncbi.nlm.nih.gov/pubmed/14758024,14758024,,
170,482324,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,64789,EXO5,https://ctdbase.org/detail.go?type=gene&acc=64789,,,64789,EXO5,10090,Mus musculus (house mouse),Carbon tetrachloride results in increased expression of EXO5 mRNA,,,PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/31919559,31919559,,
171,482325,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,60412,EXOC4,https://ctdbase.org/detail.go?type=gene&acc=60412,,,60412,EXOC4,10090,Mus musculus (house mouse),Carbon tetrachloride affects the expression of EXOC4 mRNA,,,PMID:17484886,https://www.ncbi.nlm.nih.gov/pubmed/17484886,17484886,,
172,482326,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,60412,EXOC4,https://ctdbase.org/detail.go?type=gene&acc=60412,,,60412,EXOC4,10116,Rattus norvegicus (Norway rat),Carbon tetrachloride results in decreased expression of EXOC4 mRNA,,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
173,482327,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,23265,EXOC7,https://ctdbase.org/detail.go?type=gene&acc=23265,,,23265,EXOC7,10116,Rattus norvegicus (Norway rat),Carbon tetrachloride results in increased expression of EXOC7 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
174,482328,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,51013,EXOSC1,https://ctdbase.org/detail.go?type=gene&acc=51013,,,51013,EXOSC1,10090,Mus musculus (house mouse),Carbon tetrachloride results in increased expression of EXOSC1 mRNA,,,PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/31919559,31919559,,
175,482329,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,51013,EXOSC1,https://ctdbase.org/detail.go?type=gene&acc=51013,,,51013,EXOSC1,10116,Rattus norvegicus (Norway rat),Carbon tetrachloride results in decreased expression of EXOSC1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
176,482330,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,51013,EXOSC1,https://ctdbase.org/detail.go?type=gene&acc=51013,,,51013,EXOSC1,10116,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of EXOSC1 mrna]|carbon tetrachloride results in increased expression of EXOSC1 mRNA,,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
177,482331,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,51010,EXOSC3,https://ctdbase.org/detail.go?type=gene&acc=51010,,,51010,EXOSC3,10090,Mus musculus (house mouse),Carbon tetrachloride results in increased expression of EXOSC3 mRNA,,,PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/31919559,31919559,,
178,482678,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,2146,EZH2,https://ctdbase.org/detail.go?type=gene&acc=2146,,,2146,EZH2,10090,Mus musculus (house mouse),Carbon tetrachloride results in increased expression of EZH2 mRNA,,,PMID:17484886|PMID:27339419|PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/17484886|https://www.ncbi.nlm.nih.gov/pubmed/27339419|https://www.ncbi.nlm.nih.gov/pubmed/31919559,17484886|27339419|31919559,,
179,482679,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,7430,EZR,https://ctdbase.org/detail.go?type=gene&acc=7430,,,7430,EZR,10090,Mus musculus (house mouse),Carbon tetrachloride affects the expression of EZR mRNA,,,PMID:17484886,https://www.ncbi.nlm.nih.gov/pubmed/17484886,17484886,,
180,482680,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,7430,EZR,https://ctdbase.org/detail.go?type=gene&acc=7430,,,7430,EZR,10090,Mus musculus (house mouse),Carbon tetrachloride results in increased expression of EZR mRNA,,,PMID:27339419|PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/27339419|https://www.ncbi.nlm.nih.gov/pubmed/31919559,27339419|31919559,,
181,482681,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,2159,F10,https://ctdbase.org/detail.go?type=gene&acc=2159,,,2159,F10,10090,Mus musculus (house mouse),Carbon tetrachloride results in decreased expression of F10 mRNA,,,PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/31919559,31919559,,
182,555885,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,51365,PLA1A,https://ctdbase.org/detail.go?type=gene&acc=51365,,,51365,PLA1A,10090,Mus musculus (house mouse),Carbon tetrachloride results in decreased expression of PLA1A mRNA,,,PMID:27339419|PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/27339419|https://www.ncbi.nlm.nih.gov/pubmed/31919559,27339419|31919559,,
183,555886,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,51365,PLA1A,https://ctdbase.org/detail.go?type=gene&acc=51365,,,51365,PLA1A,10116,Rattus norvegicus (Norway rat),Carbon tetrachloride results in decreased expression of PLA1A mRNA,,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
184,555887,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,81579,PLA2G12A,https://ctdbase.org/detail.go?type=gene&acc=81579,,,81579,PLA2G12A,10090,Mus musculus (house mouse),Carbon tetrachloride results in increased expression of PLA2G12A mRNA,,,PMID:27339419|PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/27339419|https://www.ncbi.nlm.nih.gov/pubmed/31919559,27339419|31919559,,
185,481831,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,1051,CEBPB,https://ctdbase.org/detail.go?type=gene&acc=1051,,,1051,CEBPB,10116,Rattus norvegicus (Norway rat),Testosterone inhibits the reaction [dexamethasone results in increased expression of CEBPB mrna],,,PMID:20032058,https://www.ncbi.nlm.nih.gov/pubmed/20032058,20032058,,
186,481832,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,1052,CEBPD,https://ctdbase.org/detail.go?type=gene&acc=1052,,,1052,CEBPD,9606,Homo sapiens (human),Testosterone results in decreased expression of CEBPD mrna|[testosterone co-treated with calcitriol] results in increased expression of CEBPD mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
187,481833,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,1052,CEBPD,https://ctdbase.org/detail.go?type=gene&acc=1052,,,1052,CEBPD,10116,Rattus norvegicus (Norway rat),Testosterone inhibits the reaction [dexamethasone results in increased expression of CEBPD mrna],,,PMID:20032058,https://www.ncbi.nlm.nih.gov/pubmed/20032058,20032058,,
188,481834,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,1053,CEBPE,https://ctdbase.org/detail.go?type=gene&acc=1053,,,1053,CEBPE,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of CEBPE mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
189,481835,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,1056,CEL,https://ctdbase.org/detail.go?type=gene&acc=1056,,,1056,CEL,9606,Homo sapiens (human),Testosterone results in decreased expression of CEL mrna|[testosterone co-treated with calcitriol] results in decreased expression of CEL mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
190,481836,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,1990,CELA1,https://ctdbase.org/detail.go?type=gene&acc=1990,,,1990,CELA1,10090,Mus musculus (house mouse),"Testosterone deficiency results in decreased expression of CELA1 mrna|1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [testosterone deficiency results in decreased expression of CELA1 mrna]",,,PMID:33848595,https://www.ncbi.nlm.nih.gov/pubmed/33848595,33848595,,
191,481837,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,10659,CELF2,https://ctdbase.org/detail.go?type=gene&acc=10659,,,10659,CELF2,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of CELF2 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
192,481838,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,11189,CELF3,https://ctdbase.org/detail.go?type=gene&acc=11189,,,11189,CELF3,9606,Homo sapiens (human),Testosterone results in increased expression of CELF3 mRNA,,,PMID:33359661,https://www.ncbi.nlm.nih.gov/pubmed/33359661,33359661,,
193,481839,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,9620,CELSR1,https://ctdbase.org/detail.go?type=gene&acc=9620,,,9620,CELSR1,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of CELSR1 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
194,482868,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,629,CFB,https://ctdbase.org/detail.go?type=gene&acc=629,,,629,CFB,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of CFB mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
195,482869,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,3426,CFI,https://ctdbase.org/detail.go?type=gene&acc=3426,,,3426,CFI,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of CFI mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
196,484395,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,1145,CHRNE,https://ctdbase.org/detail.go?type=gene&acc=1145,,,1145,CHRNE,9606,Homo sapiens (human),Testosterone results in increased expression of CHRNE mrna|[testosterone co-treated with calcitriol] results in increased expression of CHRNE mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
197,484396,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,63922,CHTF18,https://ctdbase.org/detail.go?type=gene&acc=63922,,,63922,CHTF18,9606,Homo sapiens (human),[testosterone co-treated with calcitriol] results in decreased expression of CHTF18 mrna|testosterone results in decreased expression of CHTF18 mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
198,556210,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,4987,OPRL1,https://ctdbase.org/detail.go?type=gene&acc=4987,,,4987,OPRL1,9606,Homo sapiens (human),Bisphenol A results in decreased methylation of OPRL1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
199,556211,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,4987,OPRL1,https://ctdbase.org/detail.go?type=gene&acc=4987,,,4987,OPRL1,10090,Mus musculus (house mouse),Bisphenol A results in decreased methylation of OPRL1 promoter,,,PMID:27312807,https://www.ncbi.nlm.nih.gov/pubmed/27312807,27312807,,
200,556212,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,4987,OPRL1,https://ctdbase.org/detail.go?type=gene&acc=4987,,,4987,OPRL1,90988,Pimephales promelas (fathead minnow),Bisphenol A affects the expression of OPRL1 mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
